Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124841367 | 12484136 | 7 | F | 201605 | 20160715 | 20160621 | 20160722 | EXP | US-GILEAD-2016-0216543 | GILEAD | 57.00 | YR | A | F | Y | 68.00000 | KG | 20160722 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124841367 | 12484136 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 5 MG, QD | 1412805A | 22081 | 5 | MG | TABLET | QD | |||||
| 124841367 | 12484136 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK | N | 0 | |||||||||
| 124841367 | 12484136 | 3 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 18-54 UG, QID | N | 2100758 | 0 | QID | |||||||
| 124841367 | 12484136 | 4 | SS | TYVASO | TREPROSTINIL | 1 | Unknown | UNK | N | 2100810 | 0 | ||||||||
| 124841367 | 12484136 | 5 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124841367 | 12484136 | 1 | Pulmonary arterial hypertension |
| 124841367 | 12484136 | 2 | Product used for unknown indication |
| 124841367 | 12484136 | 3 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124841367 | 12484136 | OT |
| 124841367 | 12484136 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124841367 | 12484136 | Angiopathy | |
| 124841367 | 12484136 | Balance disorder | |
| 124841367 | 12484136 | Cerebrovascular accident | |
| 124841367 | 12484136 | Confusional state | |
| 124841367 | 12484136 | Disorientation | |
| 124841367 | 12484136 | Dizziness | |
| 124841367 | 12484136 | Dysarthria | |
| 124841367 | 12484136 | Facial paresis | |
| 124841367 | 12484136 | Fatigue | |
| 124841367 | 12484136 | Hallucination | |
| 124841367 | 12484136 | Headache | |
| 124841367 | 12484136 | Hypotension | |
| 124841367 | 12484136 | Memory impairment | |
| 124841367 | 12484136 | Migraine | |
| 124841367 | 12484136 | Peripheral swelling | |
| 124841367 | 12484136 | Unevaluable event | |
| 124841367 | 12484136 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124841367 | 12484136 | 1 | 201605 | 0 | ||
| 124841367 | 12484136 | 2 | 201605 | 0 | ||
| 124841367 | 12484136 | 3 | 20160512 | 0 |